AJMC June 29, 2022
Rose McNulty

Research presented at the 2022 American Society of Clinical Oncology Annual Meeting shows White patients with myelodysplastic syndrome (MDS) have worse overall survival outcomes than African American patients, contrary to previous findings in other cancer types.

Disparities in cancer care and outcomes between African American patients and White patients have been demonstrated in past studies, with African American patients often experiencing worse outcomes. Regarding myelodysplastic syndrome (MDS), however, an abstract presented at the 2022 American Society of Clinical Oncology Annual Meeting shows White patients to have worse overall survival (OS) outcomes than African Americans patients.

MDS encompasses a group of clonal myeloid neoplasms first defined as malignant in 2001. The causes of MDS are often unknown, but in some cases,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, Equity/SDOH, Healthcare System, Patient / Consumer, Population Health Mgmt, Provider, Survey / Study, Trends
San Francisco hospital receives health equity award from Kaiser, Joint Commission
Inequality in health outcomes in the US: Can we measure this?
Podcast: AAMC Is Working To Thread Healthy Outcomes Through Health Equity
A Year of Bold Progress: IFDHE's Journey Towards Health Equity in 2024
U.S. Has Made Little Progress With Health Equity, Expert Says

Share This Article